About this trial
The long-term goal of our work is to evaluate the effect of intensive postpartum blood pressure control on maternal cardiovascular health, risk of chronic hypertension, and reversal of vascular dysfunction generated by hypertensive disorders of pregnancy, thus attenuating the lifelong trajectory of cardiovascular disease risk.
Eligibility criteria
Qualifiers
Hypertensive disorders of pregnancy (HDP) diagnosis, specifically gestational hypertension, preeclampsia, eclampsia, or HELLP syndrome, according to ACOG guidelines
Postpartum day 0-4
Age ≥ 18 years
Able to communicate in English or in Spanish
Disqualifiers
Pre-gestational hypertension
Type 1 or type 2 diabetes mellitus
Admitted to intensive care unit at the time of screening
Diagnosed with HDP during postpartum readmission after discharge from delivery hospitalization
Trial design
Treatments tested in this trial
- Nifedipine ER
Treatment groups
Sponsors and collaborators
Medical College of Wisconsin
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator